Exploring three important drug resistance mutations in ALK with three different inhibitors: insight from molecular simulations

Panminerva Med. 2023 Mar;65(1):106-107. doi: 10.23736/S0031-0808.21.04371-8. Epub 2021 Jun 11.
No abstract available

MeSH terms

  • Carcinoma, Non-Small-Cell Lung* / genetics
  • Drug Resistance
  • Drug Resistance, Neoplasm / genetics
  • Humans
  • Lung Neoplasms* / genetics
  • Mutation
  • Protein Kinase Inhibitors / pharmacology
  • Protein Kinase Inhibitors / therapeutic use
  • Receptor Protein-Tyrosine Kinases / genetics

Substances

  • Receptor Protein-Tyrosine Kinases
  • Protein Kinase Inhibitors